Prognosis of immune checkpoint inhibitors-induced myocarditis: a case series

BACKGROUND: Immune checkpoint inhibitors (ICI) have transformed cancer treatment over the last decade. Alongside this therapeutic improvement, a new variety of side effects has emerged, called immune-related adverse events (irAEs), potentially affecting any organ. Among these irAEs, myocarditis is r...

Descripción completa

Detalles Bibliográficos
Autores principales: Coustal, Cyrille, Vanoverschelde, Juliette, Quantin, Xavier, Lesage, Candice, Michot, Jean-Marie, Lappara, Ariane, Ederhy, Stephane, Assenat, Eric, Faure, Maxime, Issa, Nahema, Lambotte, Olivier, Puyade, Mathieu, Dereure, Olivier, Tosi, Diego, Rullier, Patricia, Serre, Isabelle, Larcher, Romaric, Klouche, Kada, Chanques, Gérald, Vernhet-Kovacsik, Hélène, Faillie, Jean-Luc, Agullo, Audrey, Roubille, François, Guilpain, Philippe, Maria, Alexandre Thibault Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254993/
https://www.ncbi.nlm.nih.gov/pubmed/37258037
http://dx.doi.org/10.1136/jitc-2022-004792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254993/
https://www.ncbi.nlm.nih.gov/pubmed/37258037
http://dx.doi.org/10.1136/jitc-2022-004792

Ejemplares similares